You are here: 
text zoom : S | M | L
Printer Friendly Version

ARCH
Discipline of Obstetrics and Gynaecology
The University of Adelaide

Women's and Children's Hospital
King William Road
North Adelaide SA 5006
AUSTRALIA
Email

Phone: +61 8 8161 7619
Facsimile: +61 8 8161 7652

PROGRESS: PROGesterone after previous preterm birth for prevention of neonatal RESpiratory distress Syndrome

This trial is currently recruiting. The trial is open for other centres to join the study.

Neonatal respiratory disease, due to immature lung development, is a significant consequence of preterm birth and the major cause of early neonatal mortality and morbidity. The incidence of preterm birth (birth less than 37 weeks gestation) is approximately 7.0%, with 2.6% of all births occurring before 34 weeks gestation. The exact mechanism of the onset of labour in humans is complex. Progesterone is essential for maintaining pregnancy, having an important role in uterine relaxation. Although recent reports of progesterone supplementation for women at risk of preterm birth show promise, there is currently insufficient data to recommend the use of progesterone to prevent preterm birth. This trial will involve women who have a history of spontaneous preterm birth at less than 34 weeks in the preceding pregnancy and will compare vaginal progesterone pessaries with placebo pessaries.

Chief Investigators:Prof Caroline Crowther, Dr Jodie Dodd, Dr Andrew McPhee, Ms Vicki Flenady, Prof Jeffrey Robinson
Clinical Trial Coordinator:Ms Pat Ashwood
Email:progress@adelaide.edu.au
Phone:
Fax:
61 8 8161 7767
61 8 8161 7652
Address:ARCH
Discipline of Obstetrics and Gynaecology
The University of Adelaide
Women's and Children's Hospital
King William Road
North Adelaide
South Australia 5006

Collaborating Centres:
Australia




New Zealand


Canada

Caboolture Hospital, Queensland
Ipswich Hospital, Queensland
John Hunter Hospital, New South Wales
Launceston General Hospital, Tasmania
Lyell McEwin Hospital, South Australia
Mater Mothers’ Hospital, Queensland
Mercy Hospital for Women, Victoria
Monash Medical Centre, Victoria
Nepean Hospital, New South Wales
Redcliffe Hospital, Queensland
Royal Hospital for Women, Sydney, New South Wales
Royal North Shore Hospital, New South Wales
Royal Prince Alfred Hospital Women’s & Babies Hospital, New South Wales
Royal Brisbane & Women’s Hospital, Queensland
Royal Women’s Hospital, Victoria
St George Hospital, New South Wales
Sydney Adventist Hospital, New South Wales
The Canberra Hospital, Australian Capital Territory
Toowoomba Base Hospital, Queensland
Townsville Hospital, Queensland
Westmead Hospital, New South Wales
Women's and Children's Hospital, South Australia
Christchurch Women’s Hospital, New Zealand
Dunedin Hospital, New Zealand
National Women’s Hospital, New Zealand
Palmerston North Hospital, New Zealand
Wellington Women’s Hospital, New Zealand
Mt Sinai Hospital, Toronto, Canada
British Columbia Women's Hospital, Canada

References

Dodd J, Ashwood P, Flenady V, Jenkins-Manning S, Cincotta R, Crowther CA. A Survey of clinicians and patients towards the use of progesterone for women at risk of preterm birth. Aust N Z J Obstet Gynaecol 2007;47:106-109. (IF 0.835)

Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 1.

Dodd JM, Crowther CA, Cincotta R, Flenady V & Robinson JS. Progesterone supplementation for prevention of preterm birth: a systematic review and meta-analysis. Acta Obstetrica et Gynecologica Scandinavica 2005 84, 1-8. (IF: 1.327).

Dodd JM, Flenady VJ, Cincotta R, Crowther CA. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol. 2008 Jul;112(1):127-34.